Dr. Robin L. Trotman, DO

Dr. Trotman practices at Cox North Hospital in Springfield, Missouri.

Dr. Trotman's NPI, 1205897857, was assigned on March 31, 2006. Dr. Trotman graduated from At Still University of Health Sciences, College of Osteo Med, Kirksville in 2001. Dr. Trotman holds Missouri license 2004005145.

Dr. Trotman's primary practice is Cox North Hospital, at 1423 N Jefferson Ave, Springfield, MO 65802 in Greene County. The practice phone is (417) 269-6000.

Dr. Trotman's primary practice is Cox North Hospital in Springfield, Missouri. Dr. Trotman is also affiliated with Cox Medical Center South. The medical group on file is CoxHealth Neurology. Dmand AI also links Dr. Trotman to 3 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Trotman practices, 5 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Trotman's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Trotman is licensed in Missouri.

CMS data shows 404 Medicare services from Dr. Trotman across 7 procedure codes in 2024, for 124 Medicare patients. Medicare paid $27,769 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 124 Medicare patients who saw Dr. Trotman in 2024. The largest group is 65 to 74, with 56 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Trotman's median patient age at 70, with 42% women.

In 2024, Dr. Trotman wrote 909 Medicare Part D claims for 145 patients. 71% of them were for generic drugs. CMS names the drug for 767 of them, across 18 drugs with 11 or more claims each, at $1,056,048 in total drug cost. In 2023, CMS named 539 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Trotman for performance year 2024, reported as part of a group. Dr. Trotman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Trotman as offering telehealth.

Dmand AI links 9 papers to Dr. Trotman, published from 2015 to 2022. The most frequent topics are Anti-Bacterial Agents, COVID-19 and Infectious Disease Medicine. Dr. Trotman has published most often in Clin Infect Dis. Dr. Trotman's most frequent co-authors are Steven Dale Burdette, MD, Albert L. Hsu, MD and Ann T. Macintyre, DO.

CMS Open Payments shows 84 general payments to Dr. Trotman from 13 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 84% of the total. Merck Sharp & Dohme Corporation paid the most, $17,658.

Dr. Trotman graduated from At Still University of Health Sciences, College of Osteo Med, Kirksville in 2001.